Fortis Frontier PLC (AIM:FORF)
London flag London · Delayed Price · Currency is GBP · Price in GBX
7.75
0.00 (0.00%)
At close: Mar 6, 2026

Fortis Frontier Company Description

Fortis Frontier PLC develops, distributes, and commercializes at-home healthcare and wellness tests in the United Kingdom.

The company offers general health and energy profile blood test, bowel health rapid test, and stomach ulcer rapid test; nutritional health tests, such as intolerances and sensitivities DNA tests, vitamins and minerals DNA and profile blood tests, iron deficiency rapid test, and vitamin D rapid test; and weight management tests that includes weight management DNA and blood tests, glucose management DNA tests, and thyroid profile blood test and stimulating hormone rapid test.

It also provides cardiovascular health tests, such as heart profile blood and heart profile test; women’s health tests comprising female sexual health test, polycystic ovary syndrome blood test, and menopause profile blood test; and men’s health products, including erectile dysfunction blood test, male sexual health test, and sperm concentration rapid test.

The company was formerly known as MyHealthChecked PLC and changed its name to Fortis Frontier PLC in November 2025.

Fortis Frontier PLC was incorporated in 2008 and is based in Cardiff, the United Kingdom.

Fortis Frontier PLC
Country United Kingdom
Founded 2008
Industry Shell Companies
Sector Financials
Employees 14
CEO Penelope McCormick

Contact Details

Address:
The Maltings
Cardiff, CF24 5EA
United Kingdom
Website fortisfrontier-ir.com

Stock Details

Ticker Symbol FORF
Exchange London Stock Exchange AIM
Fiscal Year January - December
Reporting Currency GBP
ISIN Number GB00BN7K5L93
SIC Code 1311

Key Executives

Name Position
Penelope McCormick Chief Executive Officer